Send feedback

DNHD1 p.Gln279Pro

c.836A>C · rs11605196 · VCV3057035

Benign No assertion criteria
Classification
Benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.1037 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 18.4%, nfe) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/2 damaging
AlphaMissense, REVEL · SaProt no call
Conditions
1
DNHD1-related disorder

Computational evidence

Protein change
AlphaMissense0.1037likely benign
REVEL0.092moderately benign-leaning
SaProt—not scored · why
⇒ AlphaMissense and REVEL both call this tolerated; SaProt makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 3.3GERP 0.54, phastCons 0.54
Regional constrainto/e 0.90unconstrained · MANE · 66 kb · p 5.3e-11 · regional, not allelic
Overall
CADD9.332PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 18.4% European (non-Finnish) · 216,743/1,179,516 alleles
Filtering AF 18.3% ClinGen BA1/BS1 input FAF95, joint · FAF99 18.3%
Overall 16.9% 271,797/1,612,914 alleles · common exomes 251,478/1,460,668 · genomes 20,319/152,246 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 22.5% 4
European (non-Finnish)grpmax 18.4% 5
Middle Eastern 17.8% 6
South Asian 17.8% 6
Remaining individualsnot grpmax-eligible 16.8% 6
Finnishnot grpmax-eligible 12.6% 8
Admixed American 12.3% 8
Amishnot grpmax-eligible 10% 10
African / African-American 5.59% 18
East Asian 2.26% 44

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
DNHD1
Protein
p.Gln279Pro
Coding
c.836A>C
MANE Select
NM_144666
dbSNP
rs11605196
Type
single nucleotide variant
Location
chr11:6502842 (GRCh38)
Gene constraint
LOEUF 0.897 · pLI <0.01 (gnomAD)
Residue 279
a UniProt-annotated variant site (in)
Full DNHD1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

DNHD1-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnhd1-p-gln279pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown